Status not kept up to date
A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery
NCT06369597 · Sun Yat-sen University · Updated 17 April 2024
- What is being tested
- Robotic telesurgery; Laparoscopic surgery
- For
- Liver Cancer; Renal Cancer; Rectal Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 75 years. About 177 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 15 April 2024, ends 31 March 2025. Registered 17 April 2024.
- Results
- None posted yet.
In the researchers' words
This is a randomized controlled trial that will be preceded by a safety trial focusing on the safety and efficacy of robotic telesurgery. The hypothesis is that robotic telesurgery has a non-inferior primary endpoint event rate to local laparoscopic surgery.
Sites
- First Affiliated Hospital, Sun Yat-Sen UniversityGuangzhou, Guangdong, China